Tyra Biosciences Watchlist

tz-plus logo Tailored medicine instead of a watering can - is Tyra Biosciences revolutionizing oncology?

T. Reich
Reading Time: 3 minutes

Tyra Biosciences is a young biotechnology company from California that is working on new drugs for cancer and rare genetic diseases. At the center of its research is a specific biological "switch" in the body that is permanently programmed for growth in some patients. When this switch becomes overactive due to a genetic defect, tumors can form, or growth disorders can occur. This is where Tyra comes in: the researchers are developing active substances aimed at specifically braking this faulty mechanism without unnecessarily disturbing other processes...

Read this article now with a free account.

Your benefits:

  • Every month, you can read 5 articles from the premium section for free.
  • Monthly 2 trial issues of the Trader newspaper for free.
  • Create a personal watchlist with an overview of news about your stock.
Trader Times
Free account
Here we go!
Image 1Image 2Image 3

Already registered? Log In